|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-11-18 Sale |
2009-11-20 5:14 pm | AVIGEN INC | AVGN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (10% owner) | 626 | $1.5 | $939 | 7,837,189 (Direct) |
View |
| 2009-10-21 Sale | 2009-10-23 4:59 pm | NEUROBIOLOGICAL TECHNOLOGIES INC | NTII | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (10% owner) | 4,606,395 | $0.91 | $4,191,819 | 331,998 (Direct) | View |
| 2009-10-21 Sale | 2009-10-23 4:57 pm |
AVIGEN INC | AVGN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (10% owner) | 472,200 | $1.5 | $708,300 | 7,837,815 (Direct) | View |
| 2009-10-16 Sale | 2009-10-20 5:17 pm | TARGACEPT INC | TRGT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (Indirect Beneficial Owner 10% owner) | 638,400 | $23.6 | $15,063,112 | 2,061,925 (Direct) |
View |
| 2009-09-22 Sale |
2009-09-24 5:14 pm |
ADOLOR CORP | ADLR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N (10% owner) | 354,000 | $1.694 | $599,706 | 4,123,551 (Direct) | View |
| 2009-09-17- -2009-09-21 Sale | 2009-09-21 6:34 pm | ADOLOR CORP | ADLR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N (10% owner) | 402,000 | $1.671 | $671,739 | 4,477,551 (Direct) | View |
| 2009-09-17 Sale | 2009-09-21 08:31 am | ARQULE INC | ARQL | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N (10% owner) | 3,680,000 | $5.25 | $19,320,000 | 8,564,073 (Direct) | View |
| 2009-09-14- -2009-09-16 Sale | 2009-09-16 4:51 pm | ADOLOR CORP | ADLR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N (10% owner) | 588,000 | $1.728 | $1,016,016 | 4,879,551 (Direct) |
View |
| 2009-09-10 Sale |
2009-09-11 5:29 pm |
DYNAVAX TECHNOLOGIES CORP | DVAX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (10% owner) | 1,212,106 | $2.765 | $3,350,988 | 4,278,851 (Direct) |
View |
| 2009-08-24 Sale |
2009-08-26 5:20 pm |
LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (Indirect Beneficial Owner 10% owner) | 4,552,550 | $2.57 | $11,700,054 | 10,617,400 (Direct) |
View |
| 2009-08-05- -2009-08-06 Sale |
2009-08-10 09:13 am | DYNAVAX TECHNOLOGIES CORP | DVAX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (10% owner) | 399,500 | $2.004 | $800,727 | 5,490,957 (Direct) | View |
| 2009-07-30 Sale | 2009-08-03 5:31 pm |
DYNAVAX TECHNOLOGIES CORP | DVAX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (10% owner) | 15,600 | $1.853 | $28,907 | 5,890,457 (Direct) |
View |
| 2009-07-27- -2009-07-29 Sale | 2009-07-29 4:44 pm | DYNAVAX TECHNOLOGIES CORP | DVAX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (10% owner) | 407,600 | $1.936 | $789,229 | 5,906,057 (Direct) |
View |
| 2009-07-14 Purchase |
2009-07-16 5:34 pm | TARGACEPT INC | TRGT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (10% owner) | 9,516 | $2.994 | $28,492 | 2,700,325 (Direct) | View |
| 2009-07-13- -2009-07-14 Sale | 2009-07-15 5:02 pm | ADOLOR CORP | ADLR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N (10% owner) | 725,500 | $1.674 | $1,214,677 | 5,467,551 (Direct) |
View |
| 2009-07-06- -2009-07-07 Sale |
2009-07-08 6:16 pm | REPLIGEN CORP | RGEN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC (Indirect Beneficial Owner 10% owner) | 451,800 | $5.516 | $2,491,978 | 2,765,050 (Direct) | View |
| 2009-06-03- -2009-06-04 Sale |
2009-06-05 4:55 pm |
DYNAVAX TECHNOLOGIES CORP | DVAX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 1,797,000 | $1.899 | $3,412,690 | 6,313,657 (Direct) | View |
| 2009-04-27 Sale |
2009-04-29 5:07 pm | CURIS INC | CRIS | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 2,970,000 | $1.15 | $3,415,500 | 5,951,716 (Indirect) | View |
| 2009-01-23- -2009-01-26 Purchase |
2009-01-27 7:09 pm | LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 43,736 | $2 | $87,472 | 16,006,215 (Indirect) | View |
| 2009-01-22- -2009-01-23 Purchase |
2009-01-26 4:54 pm | NEUROCRINE BIOSCIENCES INC | NBIX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 15,900 | $3.099 | $49,269 | 5,946,547 (Indirect) |
View |
| 2008-12-05 Purchase |
2008-12-09 5:03 pm |
COMBINATORX, INC | CRXX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 1,530,572 | $0.57 | $872,425 | 10,008,871 (Indirect) | View |
| 2008-11-21 Purchase | 2008-11-25 4:41 pm | ARQULE INC | ARQL | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 340,900 | $2.395 | $816,524 | 12,244,073 (Indirect) | View |
| 2008-11-18- -2008-11-19 Purchase | 2008-11-20 4:57 pm |
AVIGEN INC | AVGN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 158,300 | $0.7382 | $116,851 | 8,310,015 (Indirect) |
View |
| 2008-11-05 Purchase |
2008-11-07 4:32 pm |
PHARMACOPEIA INC | PCOP | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 788,000 | $0.9 | $709,200 | 4,187,839 (Indirect) | View |
| 2008-10-31 Purchase | 2008-11-04 5:19 pm | ADOLOR CORP | ADLR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 1,000 | $2.95 | $2,950 | 6,214,551 (Indirect) | View |
| 2008-10-10- -2008-10-14 Purchase |
2008-10-15 5:13 pm |
ORTHOLOGIC CORP | CAPS | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 1,186,600 | $0.6207 | $736,474 | 5,136,888 (Indirect) | View |
| 2008-09-19- -2008-09-22 Sale |
2008-09-23 5:05 pm |
NPS PHARMACEUTICALS INC | NPSP | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 474,800 | $8.651 | $4,107,388 | 4,383,115 (Indirect) | View |
| 2008-08-20 Sale | 2008-08-27 5:11 pm | SGX PHARMACEUTICALS, INC. | SGXP | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 5,507,674 | $3 | $16,523,022 | 0 (Indirect) | View |
| 2007-11-06 Purchase |
2008-06-26 5:52 pm | NEUROBIOLOGICAL TECHNOLOGIES INC | NTII | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 47,000 | $2.427 | $114,083 | 4,938,393 (Indirect) | View |
| 2008-05-09 Sale | 2008-05-13 4:51 pm | SUPERGEN INC | SUPG | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 4,300 | $2.691 | $11,573 | 5,753,399 (Indirect) | View |
| 2007-11-09 Sale | 2007-11-26 4:58 pm | VIACELL INC | VIAC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 7,305,900 | $7.25 | $52,967,775 | 0 (Indirect) |
View |
| 2005-01-13- -2006-01-13 Sale |
2006-01-13 5:34 pm | ADVANCED MAGNETICS INC | AVM | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 289,970 | $15.56 | $4,513,262 | 985,163 (Indirect) | View |
| 2004-07-07- -2004-07-08 Sale |
2004-07-09 5:50 pm | ARENA PHARMACEUTICALS INC | ARNA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 828,088 | $5.095 | $4,219,176 | 994,851 (Indirect) |
View |
| 2004-01-08 Sale(A) |
2004-01-20 4:22 pm | APPLIED MOLECULAR EVOLUTION INC | AMEV | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 917,900 | $17.8 | $16,339,246 | 721,192 (Indirect) | View |
| 2003-11-05 Sale | 2003-11-07 5:46 pm |
ARRAY BIOPHARMA INC | ARRY | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 3,865,035 | $5 | $19,325,175 | 0 (Indirect) |
View |
| 2003-10-27 Sale | 2003-10-29 5:22 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 746,000 | $8 | $5,968,000 | 1,455,900 (Indirect) | View |
| 2003-09-03 Sale | 2003-09-05 8:18 pm |
GENAERA CORP | GENR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (10% owner) | 560,000 | $4.81 | $2,693,600 | 1,668,000 (Indirect) |
View |
| 2003-08-05 Purchase | 2003-08-07 5:31 pm |
NEUROGEN CORP | NRGN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 46,000 | $4.823 | $221,841 | 2,393,663 (Indirect) | View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Ownership | Filing |
| 2006-06-06 Purchase | 2006-06-08 7:40 pm |
AEOLUS PHARMACEUTICALS, INC. | AOLS.OB | BVF PARTNERS L P BVF INC BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (Indirect Beneficial Owner 10% owner) | 475,328 | $0.5 | $237,664 | 1,778,720 (Indirect) |
View |
| 2003-08-28 Purchase |
2003-09-05 8:18 pm |
GENAERA CORP | GENR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (10% owner) | 1,428,000 | $0 | $0 | 1,938,500 (Indirect) |
View |
| 2003-07-30 Other |
2003-08-06 6:23 pm |
CORVAS INTERNATIONAL INC | CVAS | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (10% owner) | 3,010,893 | $0 | $0 | 0 (Indirect) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Ownership | Filing |
| 2008-12-23 Other |
2009-01-27 7:09 pm |
2008-12-23 2011-04-19 |
LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 31,200 | $8.59 | 31,200 (Indirect) | View |
| 2008-12-23 Other | 2009-01-27 7:09 pm |
2008-12-23 2011-04-19 |
LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 21,500 | $8.59 | 21,500 (Indirect) |
View |
| 2008-12-23 Other | 2009-01-27 7:09 pm | 2008-12-23 2011-04-19 | LIGAND PHARMACEUTICALS INC | LGND | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 83,000 | $8.59 | 83,000 (Indirect) | View |
| 2006-06-06 Purchase | 2006-06-08 7:40 pm | N/A N/A | AEOLUS PHARMACEUTICALS, INC. | AOLS.OB | BVF PARTNERS L P BVF INC BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (Indirect Beneficial Owner 10% owner) | 37,000 | $0.5 | 623,496 (Indirect) | View |
| 2006-06-06 Purchase |
2006-06-08 7:40 pm |
N/A N/A |
AEOLUS PHARMACEUTICALS, INC. | AOLS.OB | BVF PARTNERS L P BVF INC BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (Indirect Beneficial Owner 10% owner) | 24,000 | $0.5 | 599,496 (Indirect) | View |
| 2006-06-06 Purchase |
2006-06-08 7:40 pm |
N/A N/A | AEOLUS PHARMACEUTICALS, INC. | AOLS.OB | BVF PARTNERS L P BVF INC BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (Indirect Beneficial Owner 10% owner) | 57,832 | $0.5 | 541,664 (Indirect) | View |
| 2003-08-28 Purchase | 2003-09-05 8:18 pm |
2004-11-23 1998-08-08 | GENAERA CORP | GENR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (10% owner) | 450,000 | $0 | 0 (Indirect) | View |
| 2003-08-28 Purchase |
2003-09-05 8:18 pm | 2004-11-23 1998-08-08 | GENAERA CORP | GENR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (10% owner) | 285,000 | $0 | 0 (Indirect) | View |
| 2003-08-28 Purchase |
2003-09-05 8:18 pm | 2004-11-23 1998-08-08 |
GENAERA CORP | GENR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (10% owner) | 693,000 | $0 | 0 (Indirect) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 05:37:16 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |